Biotechnology in rheumatology and immunology for researchers: An overview

Biotechnology has revolutionized the fields of rheumatology and immunology, providing innovative solutions for understanding and treating autoimmune diseases. Traditionally, these fields relied on basic immunological techniques and limited therapeutic options. However, advancements in biotechnology...

Full description

Saved in:
Bibliographic Details
Main Authors: Kanishka Uthansingh, Rabindra Nath Padhy
Format: Article
Language:English
Published: Amaltea Medical Publishing House 2024-06-01
Series:Romanian Journal of Rheumatology
Subjects:
Online Access:https://rjr.com.ro/articles/2024.2/RJR_2024_2_Art-05.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850257351819395072
author Kanishka Uthansingh
Rabindra Nath Padhy
author_facet Kanishka Uthansingh
Rabindra Nath Padhy
author_sort Kanishka Uthansingh
collection DOAJ
description Biotechnology has revolutionized the fields of rheumatology and immunology, providing innovative solutions for understanding and treating autoimmune diseases. Traditionally, these fields relied on basic immunological techniques and limited therapeutic options. However, advancements in biotechnology have introduced novel diagnostic tools, targeted therapies, and personalized medicine approaches, significantly improving patient outcomes. The aim of this overview is to provide researchers with a comprehensive understanding of the current biotechnological advancements in rheumatology and immunology, highlighting their impact on disease diagnosis, management, and treatment. The primary objective is to explore the various biotechnological innovations that have transformed rheumatology and immunology. This includes the development of biologics, biomarkers, and genetic tools that have enabled precise diagnosis and tailored treatments. Additionally, the overview seeks to examine the ongoing research and future directions in these fields, emphasizing the potential for further breakthroughs. Biotechnology has significantly advanced the fields of rheumatology and immunology, offering new hope for patients with autoimmune diseases. The introduction of biologics has been a game-changer, allowing for targeted therapies that have improved disease management and patient quality of life. Biomarker discovery has enhanced diagnostic accuracy and enabled the monitoring of disease progression. Genetic and genomic tools have paved the way for personalized medicine, tailoring treatments to individual patient profiles. As research continues to evolve, the integration of biotechnology in these fields promises to bring even more innovative solutions, ultimately transforming the landscape of autoimmune disease treatment and management. Researchers must stay abreast of these developments to continue driving progress and improving patient outcomes.
format Article
id doaj-art-bd73e70101304a4aa41b4d9b8d4751c8
institution OA Journals
issn 1843-0791
2069-6086
language English
publishDate 2024-06-01
publisher Amaltea Medical Publishing House
record_format Article
series Romanian Journal of Rheumatology
spelling doaj-art-bd73e70101304a4aa41b4d9b8d4751c82025-08-20T01:56:27ZengAmaltea Medical Publishing HouseRomanian Journal of Rheumatology1843-07912069-60862024-06-0133212512910.37897/RJR.2024.2.5Biotechnology in rheumatology and immunology for researchers: An overviewKanishka Uthansingh0Rabindra Nath Padhy1Central Research Laboratory, Institute of Medical Sciences and SUM Hospital, Siksha O Anusandhan deemed to be University, Bhubaneswar, IndiaCentral Research Laboratory, Institute of Medical Sciences and SUM Hospital, Siksha O Anusandhan deemed to be University, Bhubaneswar, IndiaBiotechnology has revolutionized the fields of rheumatology and immunology, providing innovative solutions for understanding and treating autoimmune diseases. Traditionally, these fields relied on basic immunological techniques and limited therapeutic options. However, advancements in biotechnology have introduced novel diagnostic tools, targeted therapies, and personalized medicine approaches, significantly improving patient outcomes. The aim of this overview is to provide researchers with a comprehensive understanding of the current biotechnological advancements in rheumatology and immunology, highlighting their impact on disease diagnosis, management, and treatment. The primary objective is to explore the various biotechnological innovations that have transformed rheumatology and immunology. This includes the development of biologics, biomarkers, and genetic tools that have enabled precise diagnosis and tailored treatments. Additionally, the overview seeks to examine the ongoing research and future directions in these fields, emphasizing the potential for further breakthroughs. Biotechnology has significantly advanced the fields of rheumatology and immunology, offering new hope for patients with autoimmune diseases. The introduction of biologics has been a game-changer, allowing for targeted therapies that have improved disease management and patient quality of life. Biomarker discovery has enhanced diagnostic accuracy and enabled the monitoring of disease progression. Genetic and genomic tools have paved the way for personalized medicine, tailoring treatments to individual patient profiles. As research continues to evolve, the integration of biotechnology in these fields promises to bring even more innovative solutions, ultimately transforming the landscape of autoimmune disease treatment and management. Researchers must stay abreast of these developments to continue driving progress and improving patient outcomes.https://rjr.com.ro/articles/2024.2/RJR_2024_2_Art-05.pdfrheumatic diseasesimmunological disordersgenomicsproteomicsnext-generation sequencing (ngs)multiplex immunoassaysautoimmune diseasesprecision diagnostics
spellingShingle Kanishka Uthansingh
Rabindra Nath Padhy
Biotechnology in rheumatology and immunology for researchers: An overview
Romanian Journal of Rheumatology
rheumatic diseases
immunological disorders
genomics
proteomics
next-generation sequencing (ngs)
multiplex immunoassays
autoimmune diseases
precision diagnostics
title Biotechnology in rheumatology and immunology for researchers: An overview
title_full Biotechnology in rheumatology and immunology for researchers: An overview
title_fullStr Biotechnology in rheumatology and immunology for researchers: An overview
title_full_unstemmed Biotechnology in rheumatology and immunology for researchers: An overview
title_short Biotechnology in rheumatology and immunology for researchers: An overview
title_sort biotechnology in rheumatology and immunology for researchers an overview
topic rheumatic diseases
immunological disorders
genomics
proteomics
next-generation sequencing (ngs)
multiplex immunoassays
autoimmune diseases
precision diagnostics
url https://rjr.com.ro/articles/2024.2/RJR_2024_2_Art-05.pdf
work_keys_str_mv AT kanishkauthansingh biotechnologyinrheumatologyandimmunologyforresearchersanoverview
AT rabindranathpadhy biotechnologyinrheumatologyandimmunologyforresearchersanoverview